Notably, CYP7B1 influences concentrations of hydroxycholesterol and bile acid species, suggesting that the enzyme could affect immune cell abundance and plasticity in chronic inflammatory metabolic disorders such as NASH. Here, CYP7B1 is linked to metabolic dysfunction-associated steatohepatitis.